Literature DB >> 20660866

Cortical neuroanatomic correlates of symptom severity in primary progressive aphasia.

D Sapolsky1, A Bakkour, A Negreira, P Nalipinski, S Weintraub, M-M Mesulam, D Caplan, B C Dickerson.   

Abstract

OBJECTIVE: To test the validity and reliability of a new measure of clinical impairment in primary progressive aphasia (PPA), the Progressive Aphasia Severity Scale (PASS), and to investigate relationships with MRI-based cortical thickness biomarkers for localizing and quantifying the severity of anatomic abnormalities.
METHODS: Patients with PPA were rated using the PASS and underwent performance-based language testing and MRI scans that were processed for cortical thickness measures.
RESULTS: The level of impairment in PASS fluency, syntax/grammar, and word comprehension showed strong specific correlations with performance-based measures of these domains of language, and demonstrated high interrater reliability. Left inferior frontal thinning correlated with impairment in fluency and grammar/syntax, while left temporopolar thinning correlated with impairment in word comprehension. Discriminant function analysis demonstrated that a combination of left inferior frontal, left temporopolar, and left superior temporal sulcal thickness separated the 3 PPA subtypes from each other with 100% accuracy (87% accuracy in a leave-one-out analysis).
CONCLUSIONS: The PASS, a novel measure of the severity of clinical impairment within domains of language typically affected in PPA, demonstrates reliable and valid clinical-behavioral properties. Furthermore, the presence of impairment in individual PASS domains demonstrates specific relationships with focal abnormalities in particular brain regions and the severity of impairment is strongly related to the severity of anatomic abnormality within the relevant brain region. These anatomic imaging biomarkers perform well in classifying PPA subtypes. These data provide robust support for the value of this novel clinical measure and the new imaging measure as markers for potential use in clinical research and trials in PPA.

Entities:  

Mesh:

Year:  2010        PMID: 20660866      PMCID: PMC2918888          DOI: 10.1212/WNL.0b013e3181ea15e8

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  29 in total

1.  Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.

Authors:  T Gómez-Isla; J L Price; D W McKeel; J C Morris; J H Growdon; B T Hyman
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

2.  A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory.

Authors:  C J Mummery; K Patterson; C J Price; J Ashburner; R S Frackowiak; J R Hodges
Journal:  Ann Neurol       Date:  2000-01       Impact factor: 10.422

3.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest.

Authors:  Rahul S Desikan; Florent Ségonne; Bruce Fischl; Brian T Quinn; Bradford C Dickerson; Deborah Blacker; Randy L Buckner; Anders M Dale; R Paul Maguire; Bradley T Hyman; Marilyn S Albert; Ronald J Killiany
Journal:  Neuroimage       Date:  2006-03-10       Impact factor: 6.556

4.  Increasing loss of brain tissue with increasing dementia: a stereological study of post-mortem brains from elderly females.

Authors:  L Regeur
Journal:  Eur J Neurol       Date:  2000-01       Impact factor: 6.089

5.  Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience.

Authors:  J C Morris; C Ernesto; K Schafer; M Coats; S Leon; M Sano; L J Thal; P Woodbury
Journal:  Neurology       Date:  1997-06       Impact factor: 9.910

6.  Nonfluent progressive aphasia and semantic dementia: a comparative neuropsychological study.

Authors:  J R Hodges; K Patterson
Journal:  J Int Neuropsychol Soc       Date:  1996-11       Impact factor: 2.892

7.  A new clinical scale for the staging of dementia.

Authors:  C P Hughes; L Berg; W L Danziger; L A Coben; R L Martin
Journal:  Br J Psychiatry       Date:  1982-06       Impact factor: 9.319

8.  The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.

Authors:  John C Morris; Sandra Weintraub; Helena C Chui; Jeffrey Cummings; Charles Decarli; Steven Ferris; Norman L Foster; Douglas Galasko; Neill Graff-Radford; Elaine R Peskind; Duane Beekly; Erin M Ramos; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Oct-Dec       Impact factor: 2.703

9.  Slowly progressive aphasia without generalized dementia.

Authors:  M M Mesulam
Journal:  Ann Neurol       Date:  1982-06       Impact factor: 10.422

10.  Cognition and anatomy in three variants of primary progressive aphasia.

Authors:  Maria Luisa Gorno-Tempini; Nina F Dronkers; Katherine P Rankin; Jennifer M Ogar; La Phengrasamy; Howard J Rosen; Julene K Johnson; Michael W Weiner; Bruce L Miller
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

View more
  44 in total

1.  Quantitative classification of primary progressive aphasia at early and mild impairment stages.

Authors:  M-Marsel Mesulam; Christina Wieneke; Cynthia Thompson; Emily Rogalski; Sandra Weintraub
Journal:  Brain       Date:  2012-04-23       Impact factor: 13.501

2.  Naming impairment in Alzheimer's disease is associated with left anterior temporal lobe atrophy.

Authors:  Kimiko Domoto-Reilly; Daisy Sapolsky; Michael Brickhouse; Bradford C Dickerson
Journal:  Neuroimage       Date:  2012-06-21       Impact factor: 6.556

Review 3.  Towards a clearer definition of logopenic progressive aphasia.

Authors:  Cristian E Leyton; John R Hodges
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

4.  Approach to atypical Alzheimer's disease and case studies of the major subtypes.

Authors:  Bradford C Dickerson; Scott M McGinnis; Chenjie Xia; Bruce H Price; Alireza Atri; Melissa E Murray; Mario F Mendez; David A Wolk
Journal:  CNS Spectr       Date:  2017-02-15       Impact factor: 3.790

5.  Focal temporal pole atrophy and network degeneration in semantic variant primary progressive aphasia.

Authors:  Jessica A Collins; Victor Montal; Daisy Hochberg; Megan Quimby; Maria Luisa Mandelli; Nikos Makris; William W Seeley; Maria Luisa Gorno-Tempini; Bradford C Dickerson
Journal:  Brain       Date:  2016-12-31       Impact factor: 13.501

6.  Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes.

Authors:  Jordi A Matías-Guiu; María Nieves Cabrera-Martín; Teresa Moreno-Ramos; María Valles-Salgado; Marta Fernandez-Matarrubia; José Luis Carreras; Jorge Matías-Guiu
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

7.  Case 1-2017. A 70-Year-Old Woman with Gradually Progressive Loss of Language.

Authors:  M-Marsel Mesulam; Bradford C Dickerson; Janet C Sherman; Daisy Hochberg; R Gilberto Gonzalez; Keith A Johnson; Matthew P Frosch
Journal:  N Engl J Med       Date:  2017-01-12       Impact factor: 91.245

8.  Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease.

Authors:  Chenjie Xia; Sara J Makaretz; Christina Caso; Scott McGinnis; Stephen N Gomperts; Jorge Sepulcre; Teresa Gomez-Isla; Bradley T Hyman; Aaron Schultz; Neil Vasdev; Keith A Johnson; Bradford C Dickerson
Journal:  JAMA Neurol       Date:  2017-04-01       Impact factor: 18.302

9.  Selective Interference with Syntactic Encoding during Sentence Production by Direct Electrocortical Stimulation of the Inferior Frontal Gyrus.

Authors:  Edward F Chang; Garret Kurteff; Stephen M Wilson
Journal:  J Cogn Neurosci       Date:  2017-12-06       Impact factor: 3.225

10.  Clinical course of primary progressive aphasia: clinical and FDG-PET patterns.

Authors:  Jordi A Matias-Guiu; María Nieves Cabrera-Martín; Teresa Moreno-Ramos; Rocío García-Ramos; Jesús Porta-Etessam; José Luis Carreras; Jorge Matías-Guiu
Journal:  J Neurol       Date:  2014-12-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.